Replies to post #1821 on Conatus Pharmaceuticals Inc. (CNAT)

[Theo]

Interesting as there is a NEW additional NIH trial study that started up Friday (3/27/18)- NCT03479125 {Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo} They actually began recruiting in February which means they (and Novartis et. al) must've known the top-line results back then.

Study Type : Observational
Estimated Enrollment : 832 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Protocol IDN-6556-18 - A Post Treatment Follow-up Study for Liver Disease Subjects With or Without Liver Cirrhosis After Receiving Emricasan or Placebo
Actual Study Start Date : February 27, 2018
Estimated Primary Completion Date : January 31, 2022
Estimated Study Completion Date : May 31, 2022